Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

6.080 +0.150 (+2.53%)
Streaming Delayed Price Updated: 12:38 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
41 42 Next >
News headline image
Psychedelic Stock Gainers And Losers From March 10, 2022 ↗
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
News headline image
Cybin Eyes Potential Of First-Of-Its-Kind Study ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN... 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From March 9, 2022 ↗
GAINERS: ATAI Life Sciences (NASDAQ: 
Via Benzinga
News headline image
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council ↗
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From March 8, 2022 ↗
GAINERS: TripAdvisor (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 7, 2022 ↗
GAINERS: GH Research (NASDAQ: 
Via Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From March 4, 2022 ↗
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 3, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
News headline image
Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Teams with Chopra Foundation to Foster Psychedelics Awareness
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2022 ↗
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Teams Up with Chopra Foundation to Foster Psychedelics Therapy Awareness
Via Investor Brand Network
News headline image
Psychedelic Therapies Offer Hope For Mental Health ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Oppenheimer Annual Healthcare Conference
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From March 1, 2022 ↗
GAINERS: Cybin (AMEX: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2022 ↗
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
News headline image
Cybin's Study To Potentially Open New Frontiers In Psychedelics ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Cybin’s (NYSE American: CYBN) (NEO: CYBN) Study to Potentially Open New Frontiers in Psychedelics
Via Investor Brand Network
News headline image
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Feasibility Study to Potentially Open New Frontiers of Understanding Psychedelics
Via Investor Brand Network
News headline image
EXCLUSIVE: How This Company Backed By Deepak Chopra & Tony Robbins Is Disrupting Mental Health With Psychedelics ↗
Doug Drysdale, CEO of Cybin Inc. (NYSE:CYBN... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
News headline image
Small Pharma, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.